Rua Bioscience Limited logo

Exclusive NZ distribution rights for medical device

Operational Update24 November 2025RUAHealthcare

25 November 2025

FOR PUBLIC RELEASE


Rua Bioscience secures exclusive New Zealand distribution rights for medical device

Rua Bioscience is pleased to announce it has secured exclusive New Zealand distribution rights

for the Oleo Panacea, a dry herb vaporiser listed on Medsafe’s WAND database, which records

information about all medical devices supplied in New Zealand. The partnership with Oleo

marks an important strategic milestone for Rua, adding a new product category to the

company’s portfolio and creating a fresh revenue stream within the local medicinal cannabis

ecosystem.

The Oleo Panacea will be available to prescribers and patients across Aotearoa New Zealand

through Rua’s existing distribution channels. With very few registered medical devices currently

accessible to medicinal cannabis patients in New Zealand, this launch significantly enhances

patient options and reflects Rua’s commitment to patient-focused innovation.

“This agreement is another clear execution of our strategy to diversify revenue and improve

access to medicinal cannabis solutions,” said CEO Paul Naske. “By offering a high-quality device,

we are strengthening our presence in the domestic market and building new commercial

pathways to support Rua’s sustainable growth.”

Rua Bioscience expects this product to enhance patient compliance to prescribed cannabis

therapies, aligning with its purpose of delivering quality, accessible healthcare options. The

Panacea's approval status and high-quality design support Rua’s broader goals of product

integrity, patient safety, and regulatory compliance.

The device is lightweight, pocket-sized, and features rapid heating, a wide temperature range

(100°–230°C), and a long-lasting battery, making it both effective and convenient for patients.

This development follows a series of strong sales months in New Zealand and abroad, as Rua

continues to deliver on its export-led and innovation-driven growth strategy.

ENDS

The person who authorised this statement:

Paul Naske

Chief Executive Officer

paul.naske@ruabio.com

+64 21 445154

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.